Business Description
NFL Biosciences SA
ISIN : FR0014003XT0
Compare
Compare
Traded in other countries / regions
ALNFL.France82F.Germany IPO Date
2021-07-05Description
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 40.79 | |||||
Equity-to-Asset | 0.09 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -112.5 | |||||
3-Year EPS without NRI Growth Rate | -108.5 | |||||
3-Year Book Growth Rate | 14 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.12 | |||||
9-Day RSI | 60.29 | |||||
14-Day RSI | 58.77 | |||||
6-1 Month Momentum % | 46.54 | |||||
12-1 Month Momentum % | -8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.7 | |||||
Days Payable | 194.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.7 | |||||
Shareholder Yield % | -0.09 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -362.28 | |||||
ROA % | -94.09 | |||||
ROIC % | -357.92 | |||||
ROC (Joel Greenblatt) % | -94753.85 | |||||
ROCE % | -397.23 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 51.29 | |||||
Price-to-Tangible-Book | 89.33 | |||||
EV-to-EBIT | -5.67 | |||||
EV-to-EBITDA | -5.77 | |||||
Price-to-Net-Current-Asset-Value | 134 | |||||
Earnings Yield (Greenblatt) % | -17.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NFL Biosciences SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.479 | ||
Beta | 1.98 | ||
Volatility % | 121.7 | ||
14-Day RSI | 58.77 | ||
14-Day ATR (€) | 0.199564 | ||
20-Day SMA (€) | 2.4055 | ||
12-1 Month Momentum % | -8 | ||
52-Week Range (€) | 0.94 - 3.31 | ||
Shares Outstanding (Mil) | 9.61 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NFL Biosciences SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NFL Biosciences SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
NFL Biosciences SA Frequently Asked Questions
What is NFL Biosciences SA(XPAR:ALNFL)'s stock price today?
The current price of XPAR:ALNFL is €2.68. The 52 week high of XPAR:ALNFL is €3.31 and 52 week low is €0.94.
When is next earnings date of NFL Biosciences SA(XPAR:ALNFL)?
The next earnings date of NFL Biosciences SA(XPAR:ALNFL) is .
Does NFL Biosciences SA(XPAR:ALNFL) pay dividends? If so, how much?
NFL Biosciences SA(XPAR:ALNFL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |